查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590838

葡萄糖生物感测器市场：按类型、最终用途划分 - 2025-2030 年全球预测

Glucose Biosensors Market by Type (Electrochemical Biosensor, Optical Biosensor), End Use (Diagnostic Centres, Homecare, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年葡萄糖生物感测器市场规模为168.7亿美元，预计2024年将达到192.5亿美元，复合年增长率为14.62%，到2030年将达到438.6亿美元。

葡萄糖生物感测器是用于测量各种样本（例如血液）中葡萄糖浓度的分析设备，依赖感测器和生物元件。葡萄糖生物感测器的需求主要是由于糖尿病盛行率的增加以及对连续、非侵入性血糖监测以增强患者依从性和控制的需求所驱动。应用范围从医疗保健扩展到体育和食品工业等领域，用于监测和分析。典型的最终使用者包括医院、诊断中心和家庭护理机构。葡萄糖生物感测器市场受到糖尿病盛行率上升、生物感测器技术进步以及穿戴式医疗设备日益普及等因素的影响。新的商机包括整合人工智慧进行预测分析以及开发更易于使用的非侵入式感测器。鼓励企业投资研发，开发可同时监测多种生物标记的多功能生物感测器，提供更全面的健康监测解决方案。然而，市场开拓面临着开发成本高、监管障碍以及需要持续进步以满足消费者对准确性和可靠性日益增长的期望等挑战。此外，来自替代监测技术和监管环境的竞争也可能阻碍市场渗透。研究和创新应着重于透过小型化和无线通讯技术提高感测器精度、降低成本并提高用户便利性。探索与高科技公司的合作可以加速生物感测器与智慧设备的整合并扩大市场范围。市场是动态的，竞争力取决于创新，尤其是在传统医疗保健环境之外扩展应用。总体而言，如果葡萄糖生物感测器能够巧妙地克服技术挑战并满足注重健康的全球人口不断变化的需求，那么它们将呈现出强劲的成长路径。

主要市场统计
基准年[2023] 168.7亿美元
预测年份 [2024] 192.5亿美元
预测年份 [2030] 438.6亿美元
复合年增长率（%） 14.62%

市场动态：揭示快速发展的葡萄糖生物感测器市场的关键市场洞察

供需的动态交互作用正在改变葡萄糖生物感测器市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球糖尿病风险上升
    • 提高对血糖紊乱的认识并及早发现紊乱
    • 自我血糖监测设备在全球的推广
  • 市场限制因素
    • 对葡萄糖生物感测器设备准确可靠结果的担忧
  • 市场机会
    • 政府在葡萄糖紊乱的预防和治疗方面的积极努力和投资
    • 糖尿病治疗的消费者支出不断成长
  • 市场挑战
    • 不愿意使用新的治疗设备，加上血糖监测设备商业化的延迟；

波特五力：驾驭葡萄糖生物感测器市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解葡萄糖生物感测器市场的外部影响

外部宏观环境因素在塑造葡萄糖生物感测器市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解葡萄糖生物感测器市场的竞争格局

葡萄糖生物感测器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵葡萄糖生物感测器市场供应商的绩效评估

FPNV定位矩阵是评估葡萄糖生物感测器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了葡萄糖生物感测器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对葡萄糖生物感测器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球糖尿病风险上升
      • 提高对糖尿病的认识并及早发现疾病
      • 世界各地自我血糖测量设备的引进正在迅速增加。
    • 抑制因素
      • 对葡萄糖生物感测器设备准确可靠结果的担忧
    • 机会
      • 政府在糖尿病预防和治疗方面的有利措施和投资
      • 消费者在糖尿病治疗上的支出不断成长
    • 任务
      • 抵制使用新治疗设备并推迟血糖值监测设备的商业化
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章葡萄糖生物感测器市场：按类型

  • 电化学生物感测器
  • 光学生物感测器

第七章葡萄糖生物感测器市场：依最终用途

  • 诊断中心
  • 居家护理
  • 医院

第八章美洲葡萄糖生物感测器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区葡萄糖生物感测器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的葡萄糖生物感测器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Aryballe Technologies SA
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Biosensors International Group Ltd.
  • Danaher Corporation
  • Dexcom, Inc.
  • DuPont de Nemours, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Masimo Corporation
  • Molecular Devices, LLC
  • Pinnacle Technology, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-8C74ADFC07A0

The Glucose Biosensors Market was valued at USD 16.87 billion in 2023, expected to reach USD 19.25 billion in 2024, and is projected to grow at a CAGR of 14.62%, to USD 43.86 billion by 2030.

Glucose biosensors are analytical devices used for measuring glucose concentrations in various samples, such as blood, relying on a transducer and biological element. The necessity for glucose biosensors is primarily driven by the increasing prevalence of diabetes and the need for continuous and non-invasive glucose monitoring, enhancing patient compliance and management. Applications extend beyond healthcare into sectors like sports and food industries for monitoring and analysis purposes. Key end-users include hospitals, diagnostic centers, and homecare settings. The market for glucose biosensors is influenced by factors like rising diabetes prevalence, technological advancements in biosensor technology, and increasing adoption of wearable medical devices. Emerging opportunities include the integration of artificial intelligence for predictive analytics and the development of more user-friendly, non-invasive sensors. One recommendation is for businesses to invest in R&D for developing multifunctional biosensors that can monitor several biomarkers simultaneously, providing a more holistic health monitoring solution. However, market growth faces challenges such as high development costs, regulatory hurdles, and the need for continuous advancements to meet increasing consumer expectations for precision and reliability. Additionally, competition from alternative monitoring technologies and the regulatory landscape can hinder market penetration. Research and innovation should focus on improving sensor accuracy, reducing costs, and enhancing user convenience through miniaturization and wireless communication technology. Exploring partnerships with tech firms could foster advancements in biosensor integration into smart devices, expanding market reach. The market is dynamic with a competitive edge hinging on innovation, particularly in expanding applications beyond traditional healthcare settings. Overall, glucose biosensors present a robust growth avenue if technological challenges are adeptly navigated, meeting the evolving demands of a health-conscious global population.

KEY MARKET STATISTICS
Base Year [2023] USD 16.87 billion
Estimated Year [2024] USD 19.25 billion
Forecast Year [2030] USD 43.86 billion
CAGR (%) 14.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucose Biosensors Market

The Glucose Biosensors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising risk of diabetes worldwide
    • Growing awareness toward glucose disorders coupled with rising early detection of disorders
    • Overgrowing adoption of self glucose monitoring devices worldwide
  • Market Restraints
    • Concerns regarding accurate and reliable results of glucose biosensor devices
  • Market Opportunities
    • Favorable governmental initiatives and investments for prevention and treatment of glucose disorders
    • Expanding consumer expenditures for diabetes treatment
  • Market Challenges
    • Reluctance to use novel treatment devices coupled with slow rate of commercializing the glucose monitoring devices

Porter's Five Forces: A Strategic Tool for Navigating the Glucose Biosensors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucose Biosensors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucose Biosensors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucose Biosensors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucose Biosensors Market

A detailed market share analysis in the Glucose Biosensors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucose Biosensors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucose Biosensors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucose Biosensors Market

A strategic analysis of the Glucose Biosensors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucose Biosensors Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aryballe Technologies SA, Bayer AG, Bio-Rad Laboratories, Inc., Biosensors International Group Ltd., Danaher Corporation, Dexcom, Inc., DuPont de Nemours, Inc., F. Hoffmann-La Roche Ltd., Masimo Corporation, Molecular Devices, LLC, Pinnacle Technology, Inc., Siemens AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Glucose Biosensors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Electrochemical Biosensor and Optical Biosensor.
  • Based on End Use, market is studied across Diagnostic Centres, Homecare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising risk of diabetes worldwide
      • 5.1.1.2. Growing awareness toward glucose disorders coupled with rising early detection of disorders
      • 5.1.1.3. Overgrowing adoption of self glucose monitoring devices worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns regarding accurate and reliable results of glucose biosensor devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable governmental initiatives and investments for prevention and treatment of glucose disorders
      • 5.1.3.2. Expanding consumer expenditures for diabetes treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Reluctance to use novel treatment devices coupled with slow rate of commercializing the glucose monitoring devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glucose Biosensors Market, by Type

  • 6.1. Introduction
  • 6.2. Electrochemical Biosensor
  • 6.3. Optical Biosensor

7. Glucose Biosensors Market, by End Use

  • 7.1. Introduction
  • 7.2. Diagnostic Centres
  • 7.3. Homecare
  • 7.4. Hospitals

8. Americas Glucose Biosensors Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Glucose Biosensors Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Glucose Biosensors Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aryballe Technologies SA
  • 3. Bayer AG
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biosensors International Group Ltd.
  • 6. Danaher Corporation
  • 7. Dexcom, Inc.
  • 8. DuPont de Nemours, Inc.
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Masimo Corporation
  • 11. Molecular Devices, LLC
  • 12. Pinnacle Technology, Inc.
  • 13. Siemens AG
  • 14. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLUCOSE BIOSENSORS MARKET RESEARCH PROCESS
  • FIGURE 2. GLUCOSE BIOSENSORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLUCOSE BIOSENSORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. GLUCOSE BIOSENSORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLUCOSE BIOSENSORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLUCOSE BIOSENSORS MARKET DYNAMICS
  • TABLE 7. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY ELECTROCHEMICAL BIOSENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY OPTICAL BIOSENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY DIAGNOSTIC CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 100. GLUCOSE BIOSENSORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. GLUCOSE BIOSENSORS MARKET, FPNV POSITIONING MATRIX, 2023